GenSpera Inc. – “Recap: Takeaways from Bio Asia”

NEW YORK, NY / ACCESSWIRE / April 24, 2015 / GenSpera Inc. (OTCQB: GNSZ) today published a new blog post on The Chairman’s Blog, written by the Company’s Chief Executive Officer, Dr. Craig A. Dionne, Ph.D. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.

Dr. Craig Dionne blogged about the conversations from his time at Bio Asia that provided insight and information that will help the Company move forward with mipsagargin development in Asia more efficiently and effectively. “Bio Asia was an important guidepost and a part of a much longer conversation that will continue,” noted Dionne. Read the full blog post from Dr. Dionne on TheChairmansBlog.com (http://www.thechairmansblog.com/genspera/craig-dionne/takeaways-from-bio-asia/).

About GenSpera

GenSpera Inc. is a San Antonio-based biotech company that unlocks conventional thinking to conceive, design, and develop cancer therapies. GenSpera’s technology platform combines a powerful, plant-derived cytotoxin (thapsigargin) with a patented prodrug delivery system that provides for targeted release of drug candidates within tumors. GenSpera’s lead drug candidate, mipsagargin, was granted Orphan Drug designation by the U.S. Food and Drug Administration (FDA) in 2013 for evaluation in patients with hepatocellular carcinoma (liver cancer).

For additional information on GenSpera, visit www.genspera.com and connect on Twitter, LinkedIn, Facebook, YouTube and Google+.

About TheChairmansBlog.com

TheChairmansBlog.com is an exclusive, online media publication where publicly and privately held firms alike share insights about their companies and industries. TheChairmansBlog.com enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. www.thechairmansblog.com

SOURCE: TheChairmansBlog.com

ReleaseID: 428183